3rd Precision Medicine in Inflammatory Bowel Disease

Topics

• Discovering Functional Biomarkers to Identify Combination Therapies for Subtype-Driven Drug Development
• Overcome IBD Heterogeneity with Novel Biomarkers for Better Patient Stratification
• Expedite Microbiome Profiling to Refine Treatment Options with Better Biomarkers for IBD
• Better Biomarkers for Clinical Monitoring to Effectively Manage & Treat Patients in Need
• Enhancing Safety & Efficacy to Accelerate Patient Access to Personalized Drugs
• Novel Approaches to Deliver Best-In-Class IBD Drugs to Patients in Need